Bank of America Corporation 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-31 3:15 pm Sale | 2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | BANK OF AMERICA CORP BAC | 1,603,685 2.500% | -4,279,893 (-72.74%) | Filing |
| 2021-02-08 5:14 pm Purchase | 2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | BANK OF AMERICA CORP BAC | 5,883,578 9.500% | 1,185,435 (+25.23%) | Filing |